Norges Bank
ARLZ

Norges Bank’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Norges Bank’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-150,793
Closed -$665K – 2249
2016
Q4 		$665K Buy
150,793
+126,300
+516% +$600K ﹤0.01% 2101
2016
Q3 		$115K Hold
24,493
– – ﹤0.01% 2138
2016
Q2 		$81K Sell
24,493
-23,846
-49% -$90K ﹤0.01% 2169
2016
Q1 		$172K Buy
+48,339
New +$249K ﹤0.01% 2171

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Norges Bank's ARLZ Position: Q1 2017 in Review

Norges Bank sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q1 2017, closing a stake of 150,793 shares — an estimated $665K sold.

Norges Bank first reported a position in ARLZ in Q1 2016 and held it in 4 quarters. The position peaked at $665K in Q4 2016. 78 funds tracked by Wall St. Rank hold ARLZ as of Q1 2017.

  • Norges Bank reported no remaining Aralez Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
  • Norges Bank sold 150,793 Aralez Pharmaceuticals Inc. shares in Q1 2017, an estimated $665K.
  • Norges Bank first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 4 quarters.
  • Norges Bank's Aralez Pharmaceuticals Inc. position peaked at $665K in Q4 2016.
  • 78 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2017.

Based on Norges Bank's 13F filing for Q1 2017, filed 10 May 2017.